All News
Rheumatology Advocates Push for Patient Access to Care
d
ACR
Sep 28, 2023
Physician members of the American College of Rheumatology (ACR), care team members of the Association of Rheumatology Professionals (ARP), and patients living with rheumatic diseases convened on Capitol Hill this week for the annual Advocates for Arthritis conference and to support legislative so
Read Article
FDA has approved palovarotene (Sohonos) as 1st Rx for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation in place of soft and connective tissues. https://t.co/oiPMIDzqYP https://t.co/7rfozgPM9I https://t.co/V2w1X137Xa
Sep 28, 2023
Dr. Iain McInnes, Glasgow and Dr. Gerd Burmester, Berlin, discuss their perspectives on the future management of people with rheumatoid arthritis #RA
https://t.co/m9JwBlIXSK https://t.co/dMO3yrOUiz
Sep 28, 2023
Painful Truth of #Gout - affects 2–4% adults in USA, UK, & Europe; >10% Asia-Pacific pts. The global burden of gout is increasing.
- Majority of pts not on ULT
- Majority not T2T monitored
- health literacy on gout is vital https://t.co/ypomR2hhFX https://t.co/JPLLUPJkOE
Sep 28, 2023
FDA has approved subcutaneous (SC) vedolizumab (Entyvio) for maintenance in adults with moderately to severely active ulcerative colitis (UC) after induction therapy with intravenous vedolizumab https://t.co/0RD2TW1HgL https://t.co/q9IfbCee3U
Sep 28, 2023
Int'l cohort study of 431 established #PSA pts shows PsA patients w/ comorbid obesity were 2.5–3 folds less likely in remission/LDA (ORs 0.31, 0.39) vs non-obese. Obese PsA were more women, w/ higher TJC, pain, enthesitis counts & worse QOL https://t.co/OU1D14vLwv https://t.co/IhUDUd5MNv
Sep 28, 2023
QD Clinic - Bad Habits with Rheumatoid Factor
How many RF/CCP tests and when?
#RA QD Clinics are video vignettes with lessons from the clinic.
https://t.co/mwTgz2LFZj https://t.co/Yo5NItfZ1y
Sep 28, 2023
Dr. Michael Weinblatt (Boston) discusses current use and pitfalls of methotrexate in #RA in MTX Dosing and Monitoring Issues.
https://t.co/VInzZsaeAp https://t.co/Nae7qrSOu0
Sep 28, 2023
Microvascular CV Disease with Severe Psoriasis
While comorbidities, including an increased cardiovascular (CV) risk, are associated with severe psoriasis, less is known about subclinical CV disease and when it occurs in patients with psoriasis.
https://t.co/j2QG07qCHs https://t.co/PK16YwOZej
Sep 28, 2023
Dr. Jack Cush discusses the role of serology in guiding diagnosis and care in RA. He contrasts seronegativity considerations and the utility of seropositivity in managing rheumatoid arthritis. #RA
https://t.co/9DxjUqSGaY https://t.co/pyxq5RDmeI
Sep 28, 2023
Uncertainty on Pre-Clinical RA – Rheumatologist Survey Results
Sep 27, 2023
In June 2023, RheumNow surveyed US and non-US rheumatologists (Rheums) about how they consider and manage pre-clinical rheumatoid arthritis (RA) in their practice.
Read Article
NORD-STAR trial of Rx-naïve early active #RA (n=812) pts Rx w/ either MTX plus 1) conventional Rx w/ Steroid taper; 2) CZP, 3) ABA, 4) TCZ. By wk 48 CDAI remission signif higher w/ ABA 59% and CZP 52%, vs Conventioan Rx 39%. TCZ was not signif. https://t.co/Jw55pcq5rW https://t.co/y1NQeS89GP
Sep 27, 2023
An observational multicentre study of 51 #EGPA pts treated with dupilumab, which be effective in treating EGPA-related ENT Sxs. EGPA flares occurred in one-third of patients and were preceded by eosinophilia in 88%, - caution is required. https://t.co/d4BlcIH7US https://t.co/iMdZhb4tA1
Sep 27, 2023
In this video, Dr. Arthur Kavanaugh, San Diego, talks about considerations when facing difficult to treat RA and Dr. Jack Cush, Dallas, explains his approach to difficult to treat #RA.
https://t.co/eso5FtBeoT https://t.co/dA8Vc3UKES
Sep 27, 2023
Hard Decisions in #RA: MTX Dosing and Monitoring Issues
https://t.co/cJfOZugVQr https://t.co/qkhdZC1lva
Sep 27, 2023
Mark your calendars! RheumNow Live will now be taking place on January 27 & 28! You can join us on site in Dallas, TX or virtually. https://t.co/5oc1HGCfMt
Sep 27, 2023
Advice on Multi-Drug Failures in RA
What’s your next best approach to the rheumatoid arthritis (RA) patient who has failed several DMARDs and biologics?
https://t.co/52tOTpwxik https://t.co/7GCY1fl1fE
Sep 27, 2023
Microvascular CV Disease with Severe Psoriasis
Sep 26, 2023
While comorbidities, including an increased cardiovascular (CV) risk, are associated with severe psoriasis, less is known about subclinical CV disease and when it occurs in patients with psoriasis.
Read Article
RA QD Clinic: RA with Eye Problems
Features Dr. Michael Putman (Milwaukee, WI) RA patient presents with new, chronic eye redness - what are the possibilities? RA QD Clinics are video vignettes with lessons from the clinic.
https://t.co/2dWzdE1KnJ https://t.co/YzMzvt5jg2
Sep 26, 2023
Cognitive-behavioral Therapy Lessens Fibromyalgia Pain
In a recent clinical trial of patients with fibromyalgia, CBT, was superior to a matched education treatment in reducing the interfering effects of pain and other aspects of fibromyalgia daily.
https://t.co/fq5RTKAY3t https://t.co/AAjh77BW0Q
Sep 26, 2023